These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 32821048)

  • 1. Eukaryotic ribosome display for antibody discovery: A review.
    Chance R; Kang AS
    Hum Antibodies; 2024 May; ():. PubMed ID: 38788063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput sequencing of in vitro selections of mRNA-displayed peptides: data analysis and applications.
    Blanco C; Verbanic S; Seelig B; Chen IA
    Phys Chem Chem Phys; 2020 Mar; 22(12):6492-6506. PubMed ID: 31967131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivity-dependent PCR: direct, solution-phase in vitro selection for bond formation.
    Gorin DJ; Kamlet AS; Liu DR
    J Am Chem Soc; 2009 Jul; 131(26):9189-91. PubMed ID: 19522494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mRNA Display Pipeline for Protein Biosensor Construction.
    Cui Z; Ayva CE; Liew YJ; Guo Z; Mutschler R; Dreier B; Fiorito MM; Walden P; Howard CB; Ely F; Plückthun A; Pretorius C; Ungerer JP; Buckle AM; Alexandrov K
    ACS Sens; 2024 Jun; 9(6):2846-2857. PubMed ID: 38807313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streamlined protocol for mRNA display.
    Barendt PA; Ng DT; McQuade CN; Sarkar CA
    ACS Comb Sci; 2013 Feb; 15(2):77-81. PubMed ID: 23305392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin.
    Ma J; Xu X; Fu C; Xia P; Tian M; Zheng L; Chen K; Liu X; Li Y; Yu L; Zhu Q; Yu Y; Fan R; Jiang H; Li Z; Yang C; Xu C; Long Y; Wang J; Li Z
    Biomater Res; 2022 Nov; 26(1):64. PubMed ID: 36435809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directing evolution of novel ligands by mRNA display.
    Kamalinia G; Grindel BJ; Takahashi TT; Millward SW; Roberts RW
    Chem Soc Rev; 2021 Aug; 50(16):9055-9103. PubMed ID: 34165126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ribosome display: Evolution and acellular selection of molecular libraries for high affinity binder generation].
    Lagoutte P
    Med Sci (Paris); 2020; 36(8-9):717-724. PubMed ID: 32821048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome display for improved biotherapeutic molecules.
    Rothe A; Hosse RJ; Power BE
    Expert Opin Biol Ther; 2006 Feb; 6(2):177-87. PubMed ID: 16436043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
    Zahnd C; Amstutz P; Plückthun A
    Nat Methods; 2007 Mar; 4(3):269-79. PubMed ID: 17327848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribosome display: a technology for selecting and evolving proteins from large libraries.
    Dreier B; Plückthun A
    Methods Mol Biol; 2011; 687():283-306. PubMed ID: 20967617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro protein evolution by ribosome display and mRNA display.
    Lipovsek D; Plückthun A
    J Immunol Methods; 2004 Jul; 290(1-2):51-67. PubMed ID: 15261571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro display technologies: novel developments and applications.
    Amstutz P; Forrer P; Zahnd C; Plückthun A
    Curr Opin Biotechnol; 2001 Aug; 12(4):400-5. PubMed ID: 11551470
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.